Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Pharmaceutical Resources (NYSE:PRX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug  2Price hit new 52-week high ($42.20)
Location
One Ram Ridge Road
Spring Valley, NY 10977
Phone: (845) 425-7100
Fax: (845) 425-7907
Email: investor_relations@parpharm.com
Employees (last reported count): 297
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 49%
·Over the last 6 months:
 · 2 insider buys; 5,000  shares
 · 10 insider sells; 550.0K shares
  (3.6% of insider shares)
·Institutional: 17% (34% of float)
(82 institutions)
·Net Inst. Buying: 2.60M shares (+32.80%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Pharmaceutical Resources, Inc. (PRI) is a holding company that, through its subsidiaries, develops, manufactures and distributes a line of generic drugs in the United States. PRI operates primarily through its wholly owned subsidiary, Par Pharmaceutical Inc. (Par), a manufacturer and distributor of generic drugs. The Company's product line consists of both prescription and over-the-counter generic drugs. Par markets approximately 58 products, representing various dosage strengths for 22 drugs that are manufactured by PRI, and approximately 45 additional products, representing various dosage strengths for 23 drugs that are manufactured for it by other companies. Products are marketed principally in solid oral dosage form, consisting of tablets, caplets and two-piece hard-shell capsules. The Company also distributes one product in the semi-solid form of a cream.
More from Market Guide: Expanded Business Description

Financial Summary
Pharmaceutical Resources, Inc. is a holding company which, through its subsidiary Par Pharmaceutical, Inc., manufactures and distributes a broad line of generic drugs. For the six months ended 6/30/01, net sales increased 35% to $55 million. Net income totaled $4.1 million vs. a loss of $1.8 million. Revenues benefitted from the introduction of new products. Net income also reflects an increased gross margin due to more variable overhead variances.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Compensation
PayExer

Kenneth Sawyer, 54
Chairman, Pres and CEO
$482K--  
Scott Tarriff, 40
Exec. VP of Sales and Marketing
239K--  
Dennis O' Connor, 48
VP, CFO, Sec.
145K$39K
Dollar amounts are as of 30-Sep-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:PRXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Dec-2000
$5.938
Recent Price$35.00 
52-Week High
on 2-Aug-2001
$42.20 
Beta1.31 
Daily Volume (3-month avg)485.8K
Daily Volume (10-day avg)807.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+433.3%
52-Week Change
relative to S&P500
+615.4%
Share-Related Items
Market Capitalization$1.07B
Shares Outstanding30.5M
Float15.6M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 2 on 12-Mar-1987
Per-Share Data
Book Value (mrq)$2.23 
Earnings (ttm)$0.16 
Earnings (mrq)$0.07 
Sales (ttm)$3.27 
Cash (mrq)$0.01 
Valuation Ratios
Price/Book (mrq)15.67 
Price/Earnings (ttm)220.13 
Price/Sales (ttm)10.69 
Income Statements
Sales (ttm)$99.2M
EBITDA (ttm)$11.1M
Income available to common (ttm)$4.91M
Profitability
Profit Margin (ttm)5.0%
Operating Margin (ttm)8.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)5.37%
Return on Equity (ttm)8.00%
Financial Strength
Current Ratio (mrq)1.87 
Debt/Equity (mrq)0.25 
Total Cash (mrq)$235.0K
Short Interest
As of 8-Aug-2001
Shares Short1.37M
Percent of Float8.8%
Shares Short
(Prior Month)
1.20M
Short Ratio2.37 
Daily Volume579.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.